Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Repligen Corp (NQ: RGEN ) 133.17 -1.83 (-1.36%) Streaming Delayed Price Updated: 11:42 AM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Repligen Corp < Previous 1 2 3 4 5 6 Next > Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday August 02, 2023 U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped... Via Benzinga Top 5 Health Care Stocks That May Collapse In July July 24, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga What 4 Analyst Ratings Have To Say About Repligen July 06, 2023 Via Benzinga Over $6M Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying May 09, 2023 Although US stocks closed mixed on Monday, there were a few notable insider trades. Via Benzinga Looking Into Repligen's Return On Capital Employed May 08, 2023 Via Benzinga Why Repligen Stock Is Sinking Today April 25, 2023 Investors appear to be anticipating an underwhelming first-quarter report from the bioprocessing company. Via The Motley Fool Why Shares of Repligen Rose This Week January 12, 2023 The company is coming off a solid third quarter and is getting noticed by analysts. Via The Motley Fool Despite Attractive End Markets, Analyst Outlines Concerns For Repligen Stock December 07, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 July 20, 2023 Via Benzinga Repligen Expects Slower Growth In APAC, Builds Portfolio On Heels Of FlexBiosys Deal May 02, 2023 Repligen Corp (NASDAQ: RGEN) reported Q1 FY23 sales of $182.66 million, down 12% Y/Y as reported, Via Benzinga Repligen Beefs Up Process Analytics Portfolio With DRS Daylight Solutions Pact September 20, 2022 Via Benzinga Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says August 12, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 July 06, 2023 Via Benzinga This Analyst Is Bullish on Repligen's FlexBiosys Acquisition for Fluid Management Portfolio April 12, 2023 Repligen Inc (NASDAQ: RGEN) agreed to acquire FlexBiosys Inc to build its Fluid Management franchise and add a full range of single-use bioprocessing bags and assemblies. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023 March 28, 2023 Via Benzinga Earnings Scheduled For February 22, 2023 February 22, 2023 Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. Via Benzinga Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover February 06, 2023 Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. Via Investor's Business Daily Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday January 30, 2023 U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga Repligen Earnings Perspective: Return On Capital Employed November 09, 2022 Pulled from Benzinga Pro data, Repligen (NASDAQ:RGEN) posted Q3 earnings of $40.41 million, an increase from Q2 of 18.96%. Sales dropped to $200.74 million, a 3.32% decrease between quarters. Via Benzinga Recap: Repligen Q3 Earnings November 01, 2022 Repligen (NASDAQ:RGEN) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Repligen beat estimated earnings by... Via Benzinga Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday October 19, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 December 14, 2022 Via Benzinga Earnings Scheduled For November 1, 2022 November 01, 2022 Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion. Via Benzinga Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday October 20, 2022 Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... Via Benzinga Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session October 19, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. Via Benzinga MarketBeat: Week in Review 9/12 – 9/16 September 16, 2022 In volatile markets, rely on MarketBeat to keep you focused on your investment objectives. Here are some of our most popular articles from this week Via MarketBeat Topics Economy Exposures Economy Interest Rates Why Medical Products Maker Repligen May Be A Potential Buy September 15, 2022 Medical products maker Repligen has a long history of trouncing sales and earnings views, and it just boosted its full-year sales guidance. Is the stock a buy? Via MarketBeat Top-Rated Stocks: Lantheus Stock Sees Composite Rating Climb To 96 September 01, 2022 Top-rated Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. Via Investor's Business Daily Golden Cross Appears Before Repligen Investors August 26, 2022 If history is any guide, there may be good fortune ahead for shares of Repligen (NASDAQ:RGEN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... Via Benzinga Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating August 16, 2022 On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before. Via Investor's Business Daily < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.